Paduden Forte (Ibuprofen)

Ibuprofen acts on inflammatory pathways to provide analgesic and antipyretic effects.

• Mild to moderate pain: reduces pain intensity in conditions such as headache, dental pain, and musculoskeletal discomfort.
• Fever: lowers elevated body temperature associated with infections or inflammatory states.
• Inflammatory disorders: helps control inflammation in conditions like osteoarthritis and rheumatoid arthritis.

• Ibuprofen inhibits the cyclo‑oxygenase (COX‑1 and COX‑2) enzymes, decreasing the conversion of arachidonic acid to prostaglandins. This reduction in prostaglandin synthesis lowers inflammation, pain signaling, and fever generation at sites of tissue injury.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia or heartburn.
• Headache: mild to moderate intensity.
• Dizziness or vertigo.
• Skin rash or mild itching.
• Elevated blood pressure: transient increases.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulceration.
• Severe allergic reactions: anaphylaxis, angioedema.
• Hepatotoxicity or elevated liver enzymes.
• Renal impairment or acute kidney injury.
• Cardiovascular events: myocardial infarction or stroke, especially with high‑dose or prolonged use.

Before initiating therapy, consider the following safety measures:

• Assess renal function: patients with chronic kidney disease need dose adjustment or monitoring.
• Evaluate cardiovascular risk: use the lowest effective dose for the shortest duration.
• Review gastrointestinal history: avoid in individuals with active ulcers or a history of GI bleeding.
• Monitor for hypersensitivity: discontinue if rash, swelling or breathing difficulty occurs.
• Use cautiously in pregnancy, especially in the third trimester, and during lactation.
• Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Ibuprofen may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• High‑dose aspirin aspirin: combined gastrointestinal toxicity.
• Selective COX‑2 inhibitors (e.g., celecoxib): additive renal and cardiovascular risk.

Moderate Interactions (Monitor Closely):

• ACE inhibitors/ARBs: may reduce antihypertensive effect and affect renal function.
• Diuretics (loop or thiazide): potential for reduced kidney perfusion.
• Lithium: increased serum lithium levels.
• Methotrexate: decreased renal clearance leading to toxicity.
• SSRIs (e.g., fluoxetine): heightened bleeding risk.